Pharmacists Expand Access to Reproductive heaLthcare
| Status: | Recruiting |
|---|---|
| Conditions: | Contraception, Contraception |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - 51 |
| Updated: | 3/21/2019 |
| Start Date: | January 27, 2019 |
| End Date: | October 2022 |
| Contact: | Women's Health Research Unit Confidential Recruitment Line |
| Email: | whru@ohsu.edu |
| Phone: | 503-494-3666 |
Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception
Prospective cohort study of women presenting to initiate hormonal contraception, prescribed
by a clinician or pharmacist. Women will be followed for one year to assess contraceptive
continuation and unintended pregnancy rates, as well as measures of safety and acceptability.
by a clinician or pharmacist. Women will be followed for one year to assess contraceptive
continuation and unintended pregnancy rates, as well as measures of safety and acceptability.
Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit
or medical prescription, is a strategy to improve access to contraception and reduce
unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of
January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill
(HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a
medical prescription. Women over 18 years of age can either initiate or continue HCs with a
pharmacist, and women under 18 can continue a prescription.
This prospective cohort study of women presenting to initiate hormonal contraception,
prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and
incident pregnancy rates between women receiving hormonal contraception from a pharmacist
versus other prescriber. Women will be followed for one year to assess contraceptive
continuation and unintended pregnancy rates.
or medical prescription, is a strategy to improve access to contraception and reduce
unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of
January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill
(HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a
medical prescription. Women over 18 years of age can either initiate or continue HCs with a
pharmacist, and women under 18 can continue a prescription.
This prospective cohort study of women presenting to initiate hormonal contraception,
prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and
incident pregnancy rates between women receiving hormonal contraception from a pharmacist
versus other prescriber. Women will be followed for one year to assess contraceptive
continuation and unintended pregnancy rates.
Inclusion Criteria:
- Women presenting to initiate hormonal contraception at a study pharmacy
Exclusion Criteria:
- Pregnancy
- Contraindications to hormonal contraception
- Under 18 years of age
- Unable or unwilling to consent
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Phone: 503-494-3666
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
